China has made history with its first prospective clinical trial of an invasive brain-computer interface (BCI). Spearheaded by the Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) under the Chinese Academy of Sciences, Fudan University's Huashan Hospital, and leading industry partners, this landmark trial positions China as the second country globally to reach the clinical trial phase for invasive BCI technology.
The trial’s subject is a man who lost all four limbs in a high-voltage accident. Since the BCI system was implanted in March 2025, the device has operated steadily. In just two to three weeks of training, he started using his brain signals to play chess and racing games, achieving a control level comparable to someone using a computer touchpad. Imagine using your mind to rock your favorite video game – that's next-level tech! 🎮
Adding to the excitement is the neural electrode developed by CEBSIT, recognized as the world's smallest and most flexible of its kind. Its ultra-flexible design ensures minimal disruption to brain tissue, reducing potential damage and immune response. After successful tests in rodents and non-human primates, this breakthrough now offers promising applications for patients with spinal cord injuries, amputations, and other motor impairments.
This innovative leap in neural technology not only expands the horizons of brain science but also inspires hope for countless individuals. Whether you're a tech enthusiast, a professional in the business world, a student, or simply curious about the future, this breakthrough is a shining example of how advanced science can redefine what’s possible.
Reference(s):
China conducts first prospective clinical trial of invasive BCI
cgtn.com
